1-3 of 3
Cornelis J. A. Punt
Close
Sort by
Journal Articles

Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells

Gerty Schreibelt, Daniel Benitez-Ribas, Danita Schuurhuis, Annechien J. A. Lambeck, Maaike van Hout-Kuijer, Niels Schaft, Cornelis J. A. Punt, Carl G. Figdor, Gosse J. Adema, I. Jolanda M. de Vries
Journal: Blood
Blood (2010) 116 (4): 564–574.
https://doi.org/10.1182/blood-2009-11-251884
Published: 2010
Includes: Supplemental data
Journal Articles

Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-α production

Friederike Meyer-Wentrup, Daniel Benitez-Ribas, Paul J. Tacken, Cornelis J. A. Punt, Carl G. Figdor, I. Jolanda M. de Vries, Gosse J. Adema
Journal: Blood
Blood (2008) 111 (8): 4245–4253.
https://doi.org/10.1182/blood-2007-03-081398
Published: 2008
Includes: Supplemental data
Journal Articles

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibody

Paul J. Tacken, I. Jolanda M. de Vries, Karlijn Gijzen, Ben Joosten, Dayang Wu, Russell P. Rother, Susan J. Faas, Cornelis J. A. Punt, Ruurd Torensma, Gosse J. Adema, Carl G. Figdor
Journal: Blood
Blood (2005) 106 (4): 1278–1285.
https://doi.org/10.1182/blood-2005-01-0318
Published: 2005
Includes: Multimedia, Supplemental data